Skip Navigation


NDT Advance Access originally published online on July 22, 2006
Nephrology Dialysis Transplantation 2006 21(10):2943-2947; doi:10.1093/ndt/gfl355
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
21/10/2943    most recent
gfl355v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (6)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Vargha, R.
Right arrow Articles by Aufricht, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vargha, R.
Right arrow Articles by Aufricht, C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2006]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Ex vivo reversal of in vivo transdifferentiation in mesothelial cells grown from peritoneal dialysate effluents

Regina Vargha, Michaela Endemann, Klaus Kratochwill, Andrea Riesenhuber, Nikolaus Wick, Anne-Marie Krachler, Laura Malaga-Dieguez and Christoph Aufricht

Kinderdialyse, Department of Pediatrics, AKH Vienna, Medical University of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria

Correspondence and offprint requests to: Prof. Dr Christoph Aufricht, Kinderdialyse, Department of Pediatrics, AKH Wien, Waehringer Guertel 18-20, A-1090 Vienna, Austria. Email: christoph.aufricht{at}meduniwien.ac.at

Background. During peritoneal dialysis (PD), epithelial–mesenchymal transition (EMT) is likely involved in aberrant healing and progressive peritoneal fibrosis. Recently, EMT of the kidney was actively reversed into the opposite direction, into mesenchymal–epithelial transition (MET), by treatment with bone morphogenic protein-7 (BMP-7). In this study, the potential for ex vivo interconversion of in vivo transdifferentiation processes was investigated in mesothelial cells.

Methods. In vivo EMT was assessed in mesothelial cell cultures randomly grown from peritoneal effluents of seven patients on chronic PD. Then, ex vivo treatment with modulating factors was performed by incubating cobblestone-like cell cultures with transforming growth factor (TGF- ß1) and fibroblast-like cultures with BMP-7. Effects were assessed by morphological characterization, western analysis and reverse transcription–polymerase chain reaction of marker proteins ezrin and {alpha}-smooth muscle actin ({alpha}-SMA).

Results. PD caused progressive in vivo EMT with loss of the epithelial phenotype in the majority of mesothelial cell cultures over a 12-month period. EMT was reproducible by ex vivo treatment of cultured cells with TGF-ß1, converting the epithelial to the fibroblast-like phenotype. Ex vivo treatment with BMP-7 reversed in vivo and ex vivo EMT. During rhBMP-7 incubation the fibroblast-like growth pattern reversed into a more epithelial morphology, the expression of ezrin increased and {alpha}-SMA decreased.

Conclusion. Our study shows that modulating factors of transdifferentiation, such as BMP-7, may be attractive tools in the balance between normal healing and aberrant profibrotic processes in mesothelial cells during peritoneal dialysis. Peritoneal-effluent-derived mesothelial cells are not mere biomarkers for in vivo EMT in the peritoneal cavity, but also represent an assay to test ex vivo interventions to reverse the profibrotic phenotype.

Keywords: BMP-7; epithelial–mesenchymal transition; mesenchymal–epithelial transition; mesothelial cells; peritoneal dialysis; peritoneal effluent; TGF-ß1


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 pdiHome page
M. N. Schilte, J. W.A.M Celie, P. M. t. Wee, R. H.J. Beelen, and J. van den Born
FACTORS CONTRIBUTING TO PERITONEAL TISSUE REMODELING IN PERITONEAL DIALYSIS
Perit. Dial. Int., November 1, 2009; 29(6): 605 - 617.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
M.-A Yu, K.-S. Shin, J. H. Kim, Y.-I. Kim, S. S. Chung, S.-H. Park, Y.-L. Kim, and D.-H. Kang
HGF and BMP-7 Ameliorate High Glucose-Induced Epithelial-to-Mesenchymal Transition of Peritoneal Mesothelium
J. Am. Soc. Nephrol., March 1, 2009; 20(3): 567 - 581.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
I. Hirahara, Y. Ishibashi, S. Kaname, E. Kusano, and T. Fujita
Methylglyoxal induces peritoneal thickening by mesenchymal-like mesothelial cells in rats
Nephrol. Dial. Transplant., February 1, 2009; 24(2): 437 - 447.
[Abstract] [Full Text] [PDF]

Home page
 pdiHome page
Y.-L. Kim
UPDATE ON MECHANISMS OF ULTRAFILTRATION FAILURE
Perit. Dial. Int., February 1, 2009; 29(Supplement_2): S123 - S127.
[Abstract] [Full Text] [PDF]

Home page
 DMMHome page
R. Strippoli, I. Benedicto, M. L. Perez Lozano, A. Cerezo, M. Lopez-Cabrera, and M. A. del Pozo
Epithelial-to-mesenchymal transition of peritoneal mesothelial cells is regulated by an ERK/NF-{kappa}B/Snail1 pathway
Dis. Model. Mech., November 1, 2008; 1(4-5): 264 - 274.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
R. Vargha, T. O. Bender, A. Riesenhuber, M. Endemann, K. Kratochwill, and C. Aufricht
Effects of epithelial-to-mesenchymal transition on acute stress response in human peritoneal mesothelial cells
Nephrol. Dial. Transplant., November 1, 2008; 23(11): 3494 - 3500.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
C.-C. Szeto, K.-M. Chow, B. C.-H. Kwan, K.-B. Lai, K.-Y. Chung, C.-B. Leung, and P. K.-T. Li
The relationship between bone morphogenic protein-7 and peritoneal transport characteristics
Nephrol. Dial. Transplant., September 1, 2008; 23(9): 2989 - 2994.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
L. S. Aroeira, A. Aguilera, J. A. Sanchez-Tomero, M. A. Bajo, G. del Peso, J. A. Jimenez-Heffernan, R. Selgas, and M. Lopez-Cabrera
Epithelial to Mesenchymal Transition and Peritoneal Membrane Failure in Peritoneal Dialysis Patients: Pathologic Significance and Potential Therapeutic Interventions
J. Am. Soc. Nephrol., July 1, 2007; 18(7): 2004 - 2013.
[Abstract] [Full Text] [PDF]

Home page
 pdiHome page
S. Yung and T. M. Chan
MESOTHELIAL CELLS
Perit. Dial. Int., June 1, 2007; 27(Supplement_2): S110 - S115.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.